1. Home
  2. VTSI vs INKT Comparison

VTSI vs INKT Comparison

Compare VTSI & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$3.76

Market Cap

51.1M

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$10.42

Market Cap

45.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
INKT
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
45.2M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
VTSI
INKT
Price
$3.76
$10.42
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$5.00
$35.00
AVG Volume (30 Days)
50.1K
174.6K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$185,971.00
N/A
Revenue This Year
$28.39
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$189.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$6.66
52 Week High
$7.47
$76.00

Technical Indicators

Market Signals
Indicator
VTSI
INKT
Relative Strength Index (RSI) 37.06 52.93
Support Level N/A $8.48
Resistance Level $4.68 $12.97
Average True Range (ATR) 0.25 0.96
MACD -0.07 0.19
Stochastic Oscillator 18.62 63.87

Price Performance

Historical Comparison
VTSI
INKT

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: